Stratence Partners and StratioBD BD will showcase their AI-driven solutions for the pharmaceutical industry at the upcoming World EPA Congress on March 12 and 13. This collaboration combines Stratence's healthcare expertise with Stratio BD's AI technology to potentially transform pharmaceutical strategies and enhance decision-making and patient outcomes. Their participation in the congress highlights the growing importance of AI in healthcare and pharmaceutical research.
For more details on this innovative collaboration, you can read the full article on TechBullion here: